Increased Use of Emulsifiers in Processed Foods and the Links to Obesity.
Emulsifier
Gut microbiome
Metabolic syndrome
Nutrition
Obesity
Processed foods
Journal
Current gastroenterology reports
ISSN: 1534-312X
Titre abrégé: Curr Gastroenterol Rep
Pays: United States
ID NLM: 100888896
Informations de publication
Date de publication:
02 Dec 2019
02 Dec 2019
Historique:
entrez:
4
12
2019
pubmed:
4
12
2019
medline:
14
4
2020
Statut:
epublish
Résumé
The purpose of this review is to discuss the implications of the increased prevalence of emulsifiers in processed foods in daily consumption, the links to obesity both in mice and in vitro studies, and how those findings correlate with humans. There is rising interest in understanding the contributors to the obesity epidemic. One potential component recently studied has been the consumption of processed foods causing inflammatory changes leading to metabolic syndrome. This phenomenon has been shown in several mice and in vitro studies with changes in microbiome composition, elevated fasting blood glucose, hyperphagia, increased weight gain and adiposity, hepatic steatosis increased inflammatory markers, and a correlation with increased incidence of colorectal cancer. Emulsifiers are found in most foods consumed in the US population, which has increased over the years. This review focuses on understanding the initial approved safe levels of emulsifier consumption, the preceding increased use in foods with higher daily consumption than was previously tested, measuring these levels in animal models, and the positive association with obesity and metabolic syndrome. Future research will require prospectively studying emulsifier consumption more accurately along with the associated respective changes in the microbiome to determine the relationship to obesity.
Identifiants
pubmed: 31792622
doi: 10.1007/s11894-019-0723-4
pii: 10.1007/s11894-019-0723-4
doi:
Substances chimiques
Emulsifying Agents
0
Food Additives
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
61Références
World Health Organ Tech Rep Ser. ;(1000):1-162
pubmed: 29144073
Curr Obes Rep. 2014 Jun 1;3(2):248-55
pubmed: 24891985
Gut. 2017 Aug;66(8):1414-1427
pubmed: 28325746
Cell Metab. 2019 Jul 2;30(1):67-77.e3
pubmed: 31105044
Cancer Res. 2017 Jan 1;77(1):27-40
pubmed: 27821485
Gut Microbes. 2012 May-Jun;3(3):186-202
pubmed: 22572830
Nutrition. 2016 May;32(5):609-14
pubmed: 26899163
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2017 Jun;34(6):905-917
pubmed: 28346062
Int J Obes (Lond). 2006 Nov;30(11):1585-94
pubmed: 16801930
J Hepatol. 2015 Oct;63(4):1045-8
pubmed: 26095182
J Physiol Biochem. 2018 Feb;74(1):69-83
pubmed: 28488210
Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14691-6
pubmed: 20679230
Inflamm Bowel Dis. 2009 Mar;15(3):359-64
pubmed: 18844217
PLoS One. 2016 Jul 13;11(7):e0159236
pubmed: 27410967
Cell Metab. 2014 Nov 4;20(5):779-786
pubmed: 25156449
Aliment Pharmacol Ther. 2019 Jan;49(1):41-50
pubmed: 30484878
SOJ Microbiol Infect Dis. 2016;4(1):null
pubmed: 27430014
Toxicol Lett. 2017 Sep 5;279:87-95
pubmed: 28778519
Lancet. 2011 Aug 27;378(9793):804-14
pubmed: 21872749
J Diabetes Investig. 2015 Mar;6(2):109-11
pubmed: 25802716
Autoimmun Rev. 2015 Jun;14(6):479-89
pubmed: 25676324
Nature. 2015 Mar 5;519(7541):92-6
pubmed: 25731162